Description

Ethyl 6-Bromo-8-(Trifluoromethyl)Imidazo[1,2-A]Pyridine-2-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its unique imidazopyridine core functionalized with bromo and trifluoromethyl groups. This compound is of significant value for medicinal chemistry research and development, offering a versatile scaffold for the synthesis of novel bioactive molecules. It is primarily sought after by R&D teams and process chemists in the pharmaceutical and agrochemical industries for constructing complex heterocyclic targets.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential drug candidates, particularly for central nervous system (CNS) and anti-infective targets.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs due to its imidazopyridine scaffold.
• Agrochemical Development: Serves as a precursor for novel active ingredients in crop protection products.
• Chemical Biology Probes: Utilized in the development of molecular probes for studying biological pathways and target engagement.
• Custom Synthesis: Starting material for contract research organizations (CROs) and CDMOs offering bespoke chemical synthesis services.
• Library Synthesis: Enables the creation of diverse compound libraries for high-throughput screening (HTS) in drug discovery.

Basic Information

Product Name	Ethyl 6-Bromo-8-(Trifluoromethyl)Imidazo[1,2-A]Pyridine-2-Carboxylate
CAS No.	1121051-30-6
Molecular Formula	C11H7BrF3N2O2
Molecular Weight	333.09 g/mol
Synonyms	Ethyl 6-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate; 6-Bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic Acid Ethyl Ester; Imidazo[1,2-a]pyridine-2-carboxylic acid, 6-bromo-8-(trifluoromethyl)-, ethyl ester; 1121051-30-6; Ethyl 6-bromo-8-trifluoromethylimidazo[1,2-a]pyridine-2-carboxylate
EINECS	Contact for details

Quality Control

Our Ethyl 6-Bromo-8-(Trifluoromethyl)Imidazo[1,2-A]Pyridine-2-Carboxylate is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity, meeting the stringent requirements of pharmaceutical R&D. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to relevant quality management standards to support our global clientele in their regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥97.0% (Area %)
Water Content (KF)	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.